Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
The 6 a.m. CFO: How Everphone’s Veronika von Heise-Rotenburg Starts Her Day
Heise-Rotenburg shares her morning pet routine, foraging for herbs for daily homemade tea, and how narrow focus relieves her work-related stress.
By
CFO Editorial Staff
| June 1, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
The 6 a.m. CFO: How Everphone’s Veronika von Heise-Rotenburg Starts Her Day
Heise-Rotenburg shares her morning pet routine, foraging for herbs for daily homemade tea, and how narrow focus relieves her work-related stress.
By
CFO Editorial Staff
| June 1, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
drug trials
Risk & Compliance
J&J Speeds Up Timeline for Coronavirus Vaccine
After lagging behind other companies, J&J now expects to begin a late-stage study of its vaccine candidate in September.
By
Matthew Heller
| July 16, 2020
Read More
Risk & Compliance
Puma Biotech Exec Accused of Insider Trading
Robert Gadimian allegedly made $1.1 million by trading on nonpublic information he learned about Puma's breast cancer drug trials.
By
Matthew Heller
| September 30, 2016
Read More
